Latest Litigation News

Morella Corporation has initiated Federal Court proceedings against former receivers over disputed proceeds from a 2020 asset sale, aiming to recover value for shareholders without disrupting current operations.

Paladin Energy reports a 16% rise in uranium production at Langer Heinrich Mine, with strong sales and a fortified balance sheet positioning the company for growth. Exploration advances in Canada and leadership changes signal a strategic push forward.

Fletcher Building has agreed to sell its Construction Division to global giant VINCI Construction for an initial $315.6 million, with potential to rise to $334.1 million. The move marks a strategic pivot towards focused building products manufacturing.

AuKing Mining reports promising exploration results at Myoff Creek and steady progress at Koongie Park, while grappling with a failed Cloncurry acquisition and significant board changes.

London City Equities reveals a strong half-year performance with an 18% rise in investment portfolio values and a favourable legal development involving Excelsior Capital. The company anticipates increased liquidity and is actively seeking new long-term investments.

AuKing Mining announces the immediate retirement of two board members and reveals a legal dispute involving Orion Resources over the Cloncurry Gold Project, leading to a halt in their planned acquisition.

Aristocrat Leisure and Light & Wonder have resolved their high-profile intellectual property litigation with a $190 million settlement and the withdrawal of disputed games from the market.

Aristocrat Leisure and Light & Wonder have resolved a high-profile intellectual property dispute with a $190 million settlement and the withdrawal of contested games worldwide.

Ovanti Limited has raised $3 million through a discounted share placement to fund its expansion into the US buy now, pay later market and support ongoing litigation.

Structural Monitoring Systems Plc has removed director Ross Love following a Federal Court decision denying an injunction sought by Love and his associated company. The company continues to face ongoing legal proceedings amid serious workplace allegations.

Mayne Pharma reports mixed early FY26 results with strong prescription growth in Women’s Health and improved Dermatology margins, while strategic reviews and litigation loom.

Assetora Limited has obtained a Supreme Court injunction restraining external receivers, allowing its directors to maintain control while agreeing on payments to noteholders.